Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Preterm Labor, Premature Birth Clear all

Conditions: Respiratory Distress Syndrome, Hyperoxia, Prematurity
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Up to 3 Months
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix
Interventions: Cervical cerclage; Procedure
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Philadelphia, Pennsylvania • Austin, Texas

Conditions: Obstetric Labour, Premature
Interventions: GSK221149A, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 32
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 26 more

Conditions: Premature Infant Disease, Respiratory Insufficiency
Interventions: non-synchronized NIMV, Synchronized NIMV; Other
Lead sponsor: University of Miami; Other
Eligibility: Not listed
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Human Milk, Premature Birth of Newborn
Interventions: Similac Human Milk Fortifier Hydrolyzed Protein Concentrated Liquid; Dietary Supplement
Lead sponsor: St. Louis University; Other
Eligibility: Up to 2 Weeks
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Parent-Child Relations, Preterm Birth, Stress Reaction, Hospitalism in Children
Interventions: Bilateral alternating stimulation; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Vaginosis, Bacterial, Premature Birth, Birth Weight, Chorioamnionitis
Interventions: oral versus vaginal metronidazole; Drug
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 16 Years and older · Female only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Preterm Birth
Interventions: Implementation of social determinants of health screening and referral; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 882 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 7
States / cities: Denver, Colorado • Jacksonville, Florida • Detroit, Michigan + 4 more

Conditions: Serious Systemic Infections, Necrotizing Enterocolitis
Interventions: Metronidazole; Drug
Lead sponsor: Michael Cohen-Wolkowiez; Other
Eligibility: Up to 90 Days
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 3
States / cities: Orange, California • Wichita, Kansas • Durham, North Carolina

Conditions: Intermittent Hypoxemia, Acute Kidney Injury, Preterm Infant
Interventions: Not listed
Lead sponsor: Elie G. Abu Jawdeh, MD; Other
Eligibility: Up to 2 Months
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Pregnancy, Premature Rupture of Membranes, Preterm Premature Rupture of Membranes, Unfavorable Cervix
Interventions: Misoprostol, Oxytocin; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Premature Birth of Newborn
Interventions: Massage therapy; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 3 Days to 20 Weeks
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Premature Birth, Bronchopulmonary Dysplasia, Asthma
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 2 Months to 36 Months
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Enteral Feeding
Interventions: Feedings warmed with commercial warmer; Other
Lead sponsor: Advocate Center for Pediatric Research; Other
Eligibility: Not listed
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Park Ridge, Illinois

Conditions: Bilirubin Encephalopathy
Interventions: usual prescribed intralipid (UL) regimen, restricted prescribed intralipid (RL) regimen; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: Up to 27 Weeks
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Preterm Pregnancy, Premature Birth
Interventions: Educational intervention; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 3
States / cities: Boston, Massachusetts • Weymouth, Massachusetts

Conditions: Motor Delay, Premature Birth, Intraventricular Hemorrhage, Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia
Interventions: Physical Therapy intervention; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 33 Weeks to 48 Weeks
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: Preterm Infant, Development, Infant, Nutrition
Interventions: Prebiotic, Dextrose Control; Dietary Supplement
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 7 Days to 10 Days
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture), Rupture of Membranes; Premature, Rupture of Membranes; Premature, Affecting Fetus, Preterm Birth, Preterm PROM (Pregnancy), Preterm Labor
Interventions: Antibiotics, oral Azithromycin and oral Amoxicillin; Drug
Lead sponsor: Woman's; Other
Eligibility: 18 Years and older · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hypoglycemia, Infant, Small for Gestational Age, Premature Birth of Newborn, Fetal Macrosomia, Intrauterine Growth Restriction, Complication of Prematurity, Neonatal Hypoglycemia
Interventions: 40% Dextrose gel; Dietary Supplement
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 0 Hours to 1 Hour
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Premature Infants
Interventions: Standard Protein Diet, High Protein Diet; Dietary Supplement
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 14 Days and older
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypothermia
Interventions: Embrace, PCM, warming blanket; Device
Lead sponsor: Stanford University; Other
Eligibility: 1 Day to 120 Days
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Prematurity, Respiratory Distress Syndrome,Hypoxemia
Interventions: Inhaled nitric oxide, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 4 Years to 6 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prematurity
Interventions: Ultrasound; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 2 Years to 4 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care

Cerclage for Twins With Short Cervical Length ≤ 15mm

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Flow-synchronized Nasal IMV in Preterm Infants

Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein

Bilateral Infant Stimulation Study

Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy

The Social Determinants of Health Screening and Referral Project

Metronidazole Pharmacokinetics (PK) in Premature Infants

Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)

Cervical Ripening in Premature Rupture of Membranes

Effects of Massage Therapy to Induce Sleep in Preterm Infants

Assessment of Lung Structure and Function of Infants Born Prematurely

Effect of Feed Warming Method on Feeding Tolerance in the Preterm Infant Born at Less Than 30 Weeks Gestation

Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration

Optimizing Family Counseling for Anticipated Extremely Preterm Delivery

Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Prebiotic in Preterm Infants

Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Dextrose Gel Does Not Prevent Neonatal Hypoglycemia

Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants

Clinical Performance of the Embrace Isothermal Mattress

Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants

Ultrasound, Peds Body Composition, and Neurodevelopmental Outcomes